PATTIES FOODS Market Cap ($971.60 Million)
Market Cap & Net Worth: PATTIES FOODS (PH4)
PATTIES FOODS market cap. PATTIES FOODS (F:PH4) has a market capitalization of $971.60 Million (€831.06 Million) as of October 30, 2026. Listed on the F stock exchange, this Germany-based company holds position #8748 globally and #1144 in its home market, demonstrating a -6.34% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PATTIES FOODS's stock price €0.52 by its total outstanding shares 1598199929 (1.60 Billion).
PATTIES FOODS Market Cap History (2025–2026)
PATTIES FOODS market cap history from 2025 to 2026. Data shows growth from $1.07 Billion to $971.60 Million (44.44% CAGR). Check today's stock price for PATTIES FOODS for real-time trading data and today's change.
PATTIES FOODS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PATTIES FOODS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see PH4 cash generation efficiency for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
3.95x
PATTIES FOODS's market cap is 3.95 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $1.07 Billion | $269.58 Million | -$437.00 Million | 3.95x | N/A |
Competitor Companies of PH4 by Market Capitalization
Companies near PATTIES FOODS in the global market cap rankings as of October 30, 2026. See PATTIES FOODS (PH4) net asset quality to understand what proportion of total assets are financed by equity.
Key companies related to PATTIES FOODS by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #183 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #374 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #422 globally with a market cap of $67.80 Billion USD ( AU$95.82 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #498 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #183 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $540.00 |
| #374 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $818.77 |
| #422 | CSL Ltd | AU:CSL | $67.80 Billion | AU$197.50 |
| #498 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $222.76 |
Market Capitalization of PATTIES FOODS (2025–2026)
Market capitalization of PATTIES FOODS from 2025 to today. Between 2025 and today, PATTIES FOODS's market cap moved from $1.07 Billion to $ 971.60 Million, with a yearly change of 44.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €971.60 Million | -8.77% |
| 2025 | €1.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of PATTIES FOODS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $971.60 Million USD |
| MoneyControl | $971.60 Million USD |
| MarketWatch | $971.60 Million USD |
| marketcap.company | $971.60 Million USD |
| Reuters | $971.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PATTIES FOODS
CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junctio… Read more